MOLECULAR AND CLINICOPATHOLOGICAL CLASSIFICATION OF HIGH RISK ENDOMETRIAL CANCER (EC) TREATED WITH CONCURRENT CHEMORADIATION THERAPY (CCT)

被引：0
|
作者：
Gil-Martin, M. [1 ]
Vidal, A. [2 ]
Valle, L. [3 ]
Velasco, A. [4 ]
Ventura, L. M. [5 ]
Pardo, B. [1 ]
Recalde, S. [1 ]
Sanz-Pamplona, R. [6 ]
Navarro Perez, V. [7 ]
Marin i Borras, S. [8 ]
Piulats, J. M. [1 ]
Matias-Guiu, X. [2 ]
机构：
[1] Hosp Duran & Reynals, Inst Catala Oncol, IDIBELL, Med Oncol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Bellvitge, IDIBELL, Pathol, Lhospitalet De Llobregat, Spain
[3] Inst Catala Oncol, IDIBELL, Hereditary Canc Program, Lhospitalet De Llobregat, Spain
[4] Univ Lleida, Hosp Univ Arnau de Vilanova, IRBLLEIDA, Dept Pathol & Mol Genet, Lleida, Spain
[5] IREN SUR, Med Oncol, Arequipa, Peru
[6] Inst Catala Oncol, IDIBELL, Canc Prevent & Control Program, Unit Biomarkers & Susceptibil,CIBERESP, Lhospitalet De Llobregat, Spain
[7] Inst Catala Oncol, IDIBELL, Clin Investigat Unit, Lhospitalet De Llobregat, Spain
[8] Hosp Duran & Reynals, Inst Catala Oncol, IDIBELL, Radiat Oncol, Lhospitalet De Llobregat, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-1103
引用
收藏
页码：1095 / 1095
页数：1
相关论文
共 50 条
  • [21] Adjuvant chemotherapy and chemoradiation following surgery for high-risk endometrial cancer
    Narayan, K.
    Rischin, D.
    Quinn, M.
    Goh, J. C.
    Cheuk, R.
    Obermair, A.
    Bernshaw, D.
    McClure, B.
    Milner, A.
    Mileshkin, L. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Molecular classification improves preoperative risk assessment of endometrial cancer
    Cabrera, Silvia
    Bebia, Vicente
    Lopez-Gil, Carlos
    Luzarraga-Aznar, Ana
    Denizli, Melek
    Salazar-Huayna, Lourdes
    Abdessayed, Nihed
    Castellvi, Josep
    Colas, Eva
    Gil-Moreno, Antonio
    GYNECOLOGIC ONCOLOGY, 2024, 189 : 56 - 63
  • [23] Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy
    Noticewala, Sonal S.
    Li, Nan
    Williamson, Casey W.
    Hoh, Carl K.
    Shen, Hanjie
    McHale, Michael T.
    Saenz, Cheryl C.
    Einck, John
    Plaxe, Steven
    Vaida, Florin
    Yashar, Catheryn M.
    Mell, Loren K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 797 - 805
  • [24] Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy
    Reddy, Nishitha
    Yu, Jihnhee
    Fakih, Marwan G.
    CLINICAL COLORECTAL CANCER, 2007, 6 (05) : 362 - 366
  • [25] Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy
    Noticewala, S. S.
    Li, N.
    Williamson, C. W.
    Hoh, C. K.
    Shen, H.
    McHale, M. T.
    Saenz, C. C.
    Einck, J. P.
    Plaxe, S. C.
    Yashar, C. M.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E311 - E311
  • [26] Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy
    Han, J.
    Yi, S. K.
    Hsu, C. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1324 - 1325
  • [27] Risk factors for pericardial effusion in esophageal cancer treated with definitive chemoradiation therapy
    Wei, X.
    Liu, H. H.
    Wang, S.
    Liao, Z.
    Tucker, S. L.
    Mohan, R.
    Cox, J. D.
    Komaki, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S291 - S292
  • [28] Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification
    Pijnenborg, Johanna M. A.
    van Weelden, Willem Jan
    Reijnen, Casper
    Xanthoulea, Sofia
    Romano, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 8 - +
  • [29] Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
    Leon-Castillo, Alicia
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda R.
    Mackay, Helen J.
    Leary, Alexandra
    Nijman, Hans W.
    Singh, Naveena
    Pollock, Pamela M.
    Bessette, Paul
    Fyles, Anthony
    Haie-Meder, Christine
    Smit, Vincent T. H. B. M.
    Edmondson, Richard J.
    Putter, Hein
    Kitchener, Henry C.
    Crosbie, Emma J.
    de Bruyn, Marco
    Nout, Remi A.
    Horeweg, Nanda
    Creutzberg, Carien L.
    Bosse, Tjalling
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29) : 3388 - +
  • [30] The PORTEC-3 trial for high-risk endometrial cancer: impact of molecular classification on prognosis and benefit from adjuvant therapy
    Marnitz, Simone
    Schoemig-Markiefka, Birgid
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (03) : 266 - 268
12345